Literature DB >> 16998570

The control of melanoma in New Zealand.

Mary Sneyd1, Brian Cox.   

Abstract

AIMS: This study estimated the impact of prevention, screening, early diagnosis, and treatment on the burden of melanoma in New Zealand.
METHODS: Cancer control plans and management guidelines were reviewed to identify activities that could reduce the burden of melanoma in New Zealand and an estimation was made of their effects on incidence and mortality. The base year for estimating changes in incidence and mortality was the published melanoma data for 2002.
RESULTS: The registration of melanoma increased from 1037 new registrations in 1993 to 1487 in 1994 and peaked at 1759 in 1995. In 2002 a further increase occurred, to 1842 new registrations and 235 deaths from melanoma. It is likely that 328 of the 1842 new cases of melanoma in 2002 were directly attributable to severe sunburn. A reduction of 10% in the number of people getting severely sunburnt could prevent 28 melanoma cases per year. If 2% of melanoma deaths occur in high-risk individuals, approximately 4 deaths per year could be prevented by surveillance of high-risk groups. Thin melanoma has a very good prognosis: a 10% shift in the depth distribution into the thinnest depth category would result in about 29 deaths from melanoma prevented each year.
CONCLUSIONS: The best avenues for reducing the burden of melanoma in New Zealand are prevention of excessive sun exposure and early diagnosis. Reducing severe sunburn and diagnosing a greater proportion of melanomas when they are thin would have the greatest impact on the incidence of and mortality from melanoma.

Entities:  

Mesh:

Year:  2006        PMID: 16998570

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  7 in total

Review 1.  Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature.

Authors:  Gery P Guy; Donatus U Ekwueme
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

2.  Conflicts and contradictions in current skin cancer screening guidelines.

Authors:  K Y Wojcik; L A Escobedo; K A Miller; M Hawkins; O Ahadiat; S Higgins; A Wysong; Myles Cockburn
Journal:  Curr Dermatol Rep       Date:  2017-11-04

3.  Connectedness to nature and public (skin) health perspectives: results of a representative, population-based survey among Austrian residents.

Authors:  Daniela Haluza; Stana Simic; Jan Höltge; Renate Cervinka; Hanns Moshammer
Journal:  Int J Environ Res Public Health       Date:  2014-01-20       Impact factor: 3.390

4.  Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1).

Authors:  Huizi Xiong; Qian Yu; Yu Gong; Wenjuan Chen; Yunlei Tong; Yao Wang; Hui Xu; Yuling Shi
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

5.  Management of malignant melanoma.

Authors:  Goo-Hyun Mun
Journal:  Arch Plast Surg       Date:  2012-09-12

6.  Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid.

Authors:  Mary Jane Sneyd; Claire Cameron; Brian Cox
Journal:  BMC Cancer       Date:  2014-05-22       Impact factor: 4.430

Review 7.  Cutaneous Melanoma in Asians.

Authors:  Sang Yub Kim; Sook Jung Yun
Journal:  Chonnam Med J       Date:  2016-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.